Stocktoria
Lineage Cell Therapeutics, Inc. LCTX
NYSE · stock · Biological Products, (No Diagnostic Substances) · website · IPO 1992-03-05
Lineage Cell Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 9,559,466 | $9.5M | 3.93% |
| MILLENNIUM MANAGEMENT LLC | 3,018,567 | $4.0M | 1.24% |
| RENAISSANCE TECHNOLOGIES LLC | 1,344,829 | $1.8M | 0.55% |
| CITADEL ADVISORS LLC | 465,569 | $609,896 | 0.19% |
| TWO SIGMA INVESTMENTS, LP | 54,947 | $71,981 | 0.02% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.